AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/625

Authors: ALONSO FG
Citation: Fg. Alonso, EVALUATION OF GENERIC DRUGS IN SPAIN, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 3-3

Authors: MUNIO S
Citation: S. Munio, A VISION OF THE PHARMACEUTICAL-INDUSTRY, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 5-9

Authors: CALVO G
Citation: G. Calvo, COMMENTS ON THE NOTE FOR GUIDANCE ON BIOAVAILABILITY AND BIOEQUIVALENCE IN THE EUROPEAN-UNION, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 11-11

Authors: TATO F
Citation: F. Tato, REGIONAL CLINICAL RESEARCH ETHICS COMMITTEES, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 15-18

Authors: AVENDANO C
Citation: C. Avendano, CLINICAL-TRIAL COMMITTEES IN EUROPE, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 19-19

Authors: HARRISON F
Citation: F. Harrison, CONTRACT RESEARCH ORGANIZATIONS - THEIR ROLE IN THE DEVELOPMENT OF CLINICAL RESEARCH, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 21-22

Authors: RIBO CP
Citation: Cp. Ribo, CLINICAL RESEARCH IN PRIMARY HEALTH-CARE, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 23-26

Authors: TOGNONI G
Citation: G. Tognoni, USE OF CLINICAL-PHARMACOLOGY IN EVALUATIONS AND RATIONAL DRUG-USE PROGRAMS, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 29-29

Authors: WALLEY T
Citation: T. Walley, RATIONAL PRESCRIBING IN PRIMARY-CARE - A ROLE FOR CLINICAL-PHARMACOLOGY IN EUROPE, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 31-35

Authors: LAZARO LL
Citation: Ll. Lazaro, THE SITUATION OF CLINICAL-PHARMACOLOGY IN GENERAL-PRACTICE IN SPAIN, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 37-38

Authors: MORENO CR
Citation: Cr. Moreno, THE DRUG ADVISER IN GENERAL-PRACTICE, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 41-43

Authors: IBERN P
Citation: P. Ibern, DRUG AND HEALTH OUTCOMES MEASUREMENT IN CLINICAL-PRACTICE, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 45-46

Authors: ONODERA K SASAKI K
Citation: K. Onodera et K. Sasaki, ADVANCES IN NEUROBEHAVIORAL PHARMACOLOGY (IV) - OPIOIDS, ANTINOCICEPTION AND STRESS - PROCEEDINGS OF THE 7TH ANNUAL-MEETING OF THE ESEARCHERS-SOCIETY-OF-NEUROBEHAVIORAL-PHARMACOLOGY - MARCH 22, 1998 OSAKA, JAPAN - PREFACE, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 553-553

Authors: KAMEYAMA T UKAI M SHINKAI N
Citation: T. Kameyama et al., AMELIORATIVE EFFECTS OF TACHYKININS ON SCOPOLAMINE-INDUCED IMPAIRMENTOF SPONTANEOUS-ALTERNATION PERFORMANCE IN MICE, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 555-560

Authors: ICHIHARA K KAMEI H OKUMURA K MIZUKOSHI K NAGASAKA M
Citation: K. Ichihara et al., PHARMACOLOGICAL EFFECTS OF BAM-1120, A NOVEL ERGOLINE DERIVATIVE, ON CENTRAL DOPAMINERGIC FUNCTIONS IN RATS, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 561-566

Authors: HIRANO M HIRATE K MIYAKE N
Citation: M. Hirano et al., NC-1900, A [PGLU(4),CYT(6)]AVP(4-9) ANALOG, FACILITATES THE LEARNING-PERFORMANCE OF RATS ON DELAYED-NONMATCHING-TO-SAMPLE TASK IN Y-WATER MAZE, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 567-573

Authors: MATSUNO K SENDA T KOBAYASHI T MURAI M MITA S
Citation: K. Matsuno et al., REDUCTION OF EXYL-1-[(1R)-1,2-DIPHENYLETHYL]-PIPERAZINE-INDUCED MEMORY IMPAIRMENT OF PASSIVE-AVOIDANCE PERFORMANCE BY SIGMA(1) RECEPTOR AGONISTS IN MICE, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 575-580

Authors: SATO T TAKHASHI N TANNO K KISARA K SAKURADA T SAKURADA S
Citation: T. Sato et al., COMPARISON OF OPIOID ACTIVITY BETWEEN A N-TERMINAL TETRAPEPTIDE ANALOG OF DERMORPHIN, H-TYR-D-ARG-PHE-BETA-ALA-OH AND MORPHINE, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 581-586

Authors: IMAIZUMI M MIYAZAKI S FUSHIKI T KIM K ONODERA K
Citation: M. Imaizumi et al., A TRIAL TO DETECT BEHAVIORAL-CHANGES BY SWIMMING STRESS, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 587-594

Authors: HIRAMATSU M KAMEYAMA T
Citation: M. Hiramatsu et T. Kameyama, ROLES OF KAPPA-OPIOID RECEPTOR AGONISTS IN LEARNING AND MEMORY IMPAIRMENT IN ANIMAL-MODELS, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 595-599

Authors: YAMADA K NABESHIMA T
Citation: K. Yamada et T. Nabeshima, MODULATION OF NITRIC-OXIDE PRODUCTION IN-VIVO IN THE BRAIN, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 601-605

Authors: NODA Y NABESHIMA T
Citation: Y. Noda et T. Nabeshima, NEURONAL MECHANISMS OF PHENCYCLIDINE-INDUCED PLACE AVERSION AND PREFERENCE IN THE CONDITIONED PLACE PREFERENCE TASK, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 607-611

Authors: KAMEI H KAMEYAMA T NABESHIMA T
Citation: H. Kamei et al., EFFECTS OF SIGMA-RECEPTOR LIGANDS ON CONDITIONED FEAR STRESS, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 613-618

Authors: ITOH A NODA Y MAMIYA T HASEGAWA T NABESHIMA T
Citation: A. Itoh et al., A THERAPEUTIC STRATEGY TO PREVENT MORPHINE-DEPENDENCE AND TOLERANCE BY COADMINISTRATION OF CAMP-RELATED REAGENTS WITH MORPHINE, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 619-625

Citation: ADVANCES IN NEUROBEHAVIORAL PHARMACOLOGY (IV) - OPIOIDS, ANTINOCICEPTION AND STRESS - PROCEEDINGS OF THE 7TH ANNUAL-MEETING OF THE ESEARCHERS-SOCIETY-OF-NEUROBEHAVIORAL-PHARMACOLOGY - MARCH 22, 1998 OSAKA, JAPAN - ABSTRACTS, Methods and findings in experimental and clinical pharmacology, 20(7), 1998, pp. 627-640
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>